131 related articles for article (PubMed ID: 4522081)
1. Rifampicin-dependent antibodies in twice-weekly treated patients.
Algeorge G; Rudescu D; Alexandrescu D
Scand J Respir Dis Suppl; 1973; 84():98-101. PubMed ID: 4522081
[No Abstract] [Full Text] [Related]
2. Proceedings of the Workshop on Intermittent Drug Therapy and Immunological Implications in Antituberculous Treatment with Rifampicin. Oct. 2-3, 1972 Stockholm. Organized by The Department of Thoracic Medicine, Karolinska Sjukhuset.
Scand J Respir Dis Suppl; 1973; 84():1-193. PubMed ID: 4593267
[No Abstract] [Full Text] [Related]
3. Haematological changes during intermittent treatment with rifampicin.
Wislawska-Orlowska B; Pniewski T
Scand J Respir Dis Suppl; 1973; 84():94-7. PubMed ID: 4522080
[No Abstract] [Full Text] [Related]
4. Immunological and haematological investigations on patients with adverse reactions during treatment with RMP plus INH once-weekly.
Herrmann H; Eule H
Scand J Respir Dis Suppl; 1973; 84():87-93. PubMed ID: 4593270
[No Abstract] [Full Text] [Related]
5. Controlled clinical evaluation of three intermittent regimens employing low-dosage schedules of rifampicin in original treatment of pulmonary tuberculosis. Preliminary data on effectiveness and side effects.
Nitti V
Scand J Respir Dis Suppl; 1973; 84():180-5. PubMed ID: 4593266
[No Abstract] [Full Text] [Related]
6. Side effects observed during intermittent rifampicin therapy.
Stradling P
Scand J Respir Dis Suppl; 1973; 84():129-31. PubMed ID: 4522066
[No Abstract] [Full Text] [Related]
7. Clinical aspects of side effects on intermittent rifampicin regimen.
Zierski M
Scand J Respir Dis Suppl; 1973; 84():166-73. PubMed ID: 4522072
[No Abstract] [Full Text] [Related]
8. Rifampicin-dependent antibodies during intermittent treatment.
Virgilio R
Scand J Respir Dis Suppl; 1973; 84():83-6. PubMed ID: 4593269
[No Abstract] [Full Text] [Related]
9. The intermittent chemotherapy of tuberculosis with rifampicin regimens on ambulatory basis.
Anastasatu C; Bungeteanu G; Sibila S
Scand J Respir Dis Suppl; 1973; 84():136-9. PubMed ID: 4522068
[No Abstract] [Full Text] [Related]
10. Hong Kong Treatment Services-Royal Postgraduate Medical School-British Medical Research Council Co-operative study of rifampicin plus ethambutol in daily and intermittent regimens. Correlation between the presence of rifampicin-dependent antibodies and the clinical data.
Worlledge S
Scand J Respir Dis Suppl; 1973; 84():125-8. PubMed ID: 4522065
[No Abstract] [Full Text] [Related]
11. Side effects during intermittent rifampicin and ethambutol treatment. A preliminary report.
Guerra Sanz FJ
Scand J Respir Dis Suppl; 1973; 84():160-5. PubMed ID: 4522071
[No Abstract] [Full Text] [Related]
12. [2 cases of hemolytic complications during intermittent treatment with rifampicin].
Năstase M; Brener E; Năstase R; Borgovan L
Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1975; 24(1):43-6. PubMed ID: 171722
[TBL] [Abstract][Full Text] [Related]
13. Preliminary results of a controlled therapeutic trail administering INH-RMP once-weekly, after--or without--an initial period of continuous treatment.
Eule H; Kärnbach E; Kaluza P; Herrmann H
Scand J Respir Dis Suppl; 1973; 84():153-9. PubMed ID: 4593264
[No Abstract] [Full Text] [Related]
14. Hong Kong Treatment Services-Royal Postgraduate Medical School-British Medical Research Council Co-operative study of rifampicin plus ethambutol in daily and intermittent regimens. The detection of rifampicin-dependent antibodies.
Worlledge S
Scand J Respir Dis Suppl; 1973; 84():60-3. PubMed ID: 4544603
[No Abstract] [Full Text] [Related]
15. [Thrombocytopenia caused by hypersensitivity to rifampicin in intermittent high doses].
Sepúlveda R; Soerensen R; Santiviago C; Alvarez R; Gay O; Zúñiga E; Meléndez M; Farga V
Rev Med Chil; 1971 Dec; 99(12):934-8. PubMed ID: 5168230
[No Abstract] [Full Text] [Related]
16. ["Immuno-allergic" complications of rifampicin therapy].
Bessot JC; Vandevenne A; Petitjean R; Burghard G
Poumon Coeur; 1977; 33(2):107-15. PubMed ID: 560692
[TBL] [Abstract][Full Text] [Related]
17. [Recurrent hemolytic accidents of immuno-allergic origin during intermittent treatment with rifampicin].
Sors C; Sarrazin A; Homberg JC
Rev Tuberc Pneumol (Paris); 1972; 36(3):405-16. PubMed ID: 5080967
[No Abstract] [Full Text] [Related]
18. Intermittent chemotherapy of pulmonary tuberculosis using rifampicin and isoniazid for primary treatment: the influence of various factors on the frequency of side-effects.
Eule H; Werner E; Winsel K; Iwainsky H
Tubercle; 1974 Mar; 55(1):81-9. PubMed ID: 4620295
[No Abstract] [Full Text] [Related]
19. Acute renal failure after rifampicin therapy.
Seufert CD
Scand J Respir Dis Suppl; 1973; 84():174-9. PubMed ID: 4522073
[No Abstract] [Full Text] [Related]
20. [Daily and intermittent regimens using ethambutol and rifampicin in the treatment of unresponsive cases. (Evaluation after 1 year.) II. Side effects].
Girling DJ
Bull Int Union Tuberc; 1974; 49(1):451-5. PubMed ID: 4619567
[No Abstract] [Full Text] [Related]
[Next] [New Search]
